Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3490-3496

  Koga, Tomohiro ^a   Ichinose, Kunihiro ^a   Mizui, Masayuki ^a   Crispín, José C ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CAMK4 GENE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 84866538945     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201785     Document Type: Article

References (32)

1. Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121.
2. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1: 147-153. (Pubitemid 33741968)
3. Crispín, J. C., S. N. Liossis, K. Kis-Toth, L. A. Lieberman, V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2010. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol. Med. 16: 47-57.
4. Solomou, E. E., Y. T. Juang, M. F. Gourley, G. M. Kammer, and G. C. Tsokos. 2001. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166: 4216-4222. (Pubitemid 32224956)
5. Tenbrock, K., Y. T. Juang, M. Tolnay, and G. C. Tsokos. 2003. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J. Immunol. 170: 2971-2976. (Pubitemid 36302169)
6. Hanissian, S. H., M. Frangakis, M. M. Bland, S. Jawahar, and T. A. Chatila. 1993. Expression of a Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, in human T lymphocytes. Regulation of kinase activity by T cell receptor signaling. J. Biol. Chem. 268: 20055-20063. (Pubitemid 23278901)
7. Racioppi, L., and A. R. Means. 2008. Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller. Trends Immunol. 29: 600-607.
8. Juang, Y. T., Y. Wang, E. E. Solomou, Y. Li, C. Mawrin, K. Tenbrock, V. C. Kyttaris, and G. C. Tsokos. 2005. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115: 996-1005. (Pubitemid 40489404)
9. Ichinose, K., Y. T. Juang, J. C. Crispín, K. Kis-Toth, and G. C. Tsokos. 2011. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Arthritis Rheum. 63: 523-529.
10. Ichinose, K., T. Rauen, Y. T. Juang, K. Kis-Toth, M. Mizui, T. Koga, and G. C. Tsokos. 2011. Cutting edge: calcium/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J. Immunol. 187: 5500-5504.
11. Wofsy, D., E. D. Murphy, J. B. Roths, M. J. Dauphinée, S. B. Kipper, and N. Talal. 1981. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J. Exp. Med. 154: 1671-1680. (Pubitemid 12235207)
12. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
13. Linker-Israeli, M., A. C. Bakke, R. C. Kitridou, S. Gendler, S. Gillis, and D. A. Horwitz. 1983. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130: 2651-2655.
14. Alcocer-Varela, J., and D. Alarcón-Segovia. 1982. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69: 1388-1392. (Pubitemid 12081067)
15. Altman, A., A. N. Theofilopoulos, R. Weiner, D. H. Katz, and F. J. Dixon. 1981. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med. 154: 791-808. (Pubitemid 11060789)
16. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390. (Pubitemid 15093080)
17. Lieberman, L. A., and G. C. Tsokos. 2010. The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J. Biomed. Biotechnol. 2010: 740619.
18. Means, A. R., T. J. Ribar, C. D. Kane, S. S. Hook, and K. A. Anderson. 1997. Regulation and properties of the rat Ca2+/calmodulin-dependent protein kinase IV gene and its protein products. Recent Prog. Horm. Res. 52: 389-406; discussion 406-407.
19. Almeida, A. R., N. Legrand, M. Papiernik, and A. A. Freitas. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169: 4850-4860. (Pubitemid 35217148)
20. Setoguchi, R., S. Hori, T. Takahashi, and S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735. (Pubitemid 40395118)
21. Valencia, X., C. Yarboro, G. Illei, and P. E. Lipsky. 2007. Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178: 2579-2588. (Pubitemid 46233461)
22. Parietti, V., F. Monneaux, M. Décossas, and S. Muller. 2008. Function of CD4+, CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheum. 58: 1751-1761. (Pubitemid 351847529)
23. Campbell, D. J., and M. A. Koch. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
24. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178. (Pubitemid 35245959)
25. Barath, S., M. Aleksza, T. Tarr, S. Sipka, G. Szegedi, and E. Kiss. 2007. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 16: 489-496. (Pubitemid 47242522)
26. Yan, B., S. Ye, G. Chen, M. Kuang, N. Shen, and S. Chen. 2008. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58: 801-812. (Pubitemid 351364878)
27. Gómez-Martín, D., M. Díaz-Zamudio, J. C. Crispín, and J. Alcocer-Varela. 2009. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun. Rev. 9: 34-39.
28. Kyttaris, V. C., Y. T. Juang, and G. C. Tsokos. 2005. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 17: 518-522. (Pubitemid 41527809)
29. Gutierrez-Ramos, J. C., J. L. Andreu, Y. Revilla, E. Viñuela, and C. Martinez. 1990. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 346: 271-274.
30. Koreth, J., K. Matsuoka, H. T. Kim, S. M. McDonough, B. Bindra, E. P. Alyea, III, P. Armand, C. Cutler, V. T. Ho, N. S. Treister, et al. 2011. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365: 2055-2066.
31. Saadoun, D., M. Rosenzwajg, F. Joly, A. Six, F. Carrat, V. Thibault, D. Sene, P. Cacoub, and D. Klatzmann. 2011. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365: 2067-2077.
32. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.